Order Article Reprints

Asare-Werehene M, Tsuyoshi H, Zhang H, Salehi R, Chang C-Y, Carmona E, Librach CL, Mes-Masson A-M, Chang C-C, Burger D, et al. Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes. Cancers. 2022; 14(4):1039. https://doi.org/10.3390/cancers14041039

Asare-Werehene, Meshach, Hideaki Tsuyoshi, Huilin Zhang, Reza Salehi, Chia-Yu Chang, Euridice Carmona, Clifford L. Librach, Anne-Marie Mes-Masson, Chia-Ching Chang, Dylan Burger, and et al. 2022. "Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes" Cancers 14, no. 4: 1039. https://doi.org/10.3390/cancers14041039

Asare-Werehene, M., Tsuyoshi, H., Zhang, H., Salehi, R., Chang, C.-Y., Carmona, E., Librach, C. L., Mes-Masson, A.-M., Chang, C.-C., Burger, D., Yoshida, Y., & Tsang, B. K. (2022). Plasma Gelsolin Confers Chemoresistance in Ovarian Cancer by Resetting the Relative Abundance and Function of Macrophage Subtypes. Cancers, 14(4), 1039. https://doi.org/10.3390/cancers14041039